Randomized phase II trial of pemetrexed with or without bevacizumab maintenance after cisplatin, pemetrexed and bevacizumab in advanced non-squamous, non-small cell lung cancer (TORG1321)

被引：0

作者：

Kondo, T. ^{[1
]}

Kasai, T. ^{[2
]}

Mori, K. ^{[3
,15
]}

Saito, H. ^{[1
]}

Nishikawa, K. ^{[4
]}

Otsu, S. ^{[4
]}

Seki, N. ^{[5
]}

Ichikawa, Y. ^{[5
]}

Bessho, A. ^{[6
]}

Tanaka, H. ^{[7
]}

Yamaguchi, H. ^{[8
]}

Kaburagi, T. ^{[9
]}

Kanazawa, K. ^{[10
]}

Komase, Y. ^{[11
]}

Minato, K. ^{[12
]}

Misumi, Y. ^{[13
]}

Morinaga, R. ^{[14
]}

Mori, K. ^{[3
,15
]}

Ohtake, J. ^{[16
]}

Okamoto, H. ^{[17
]}

机构：

[1] Kanagawa Canc Ctr, Dept Thorac Oncol, Yokohama, Kanagawa, Japan

[2] Tochigi Canc Ctr, Div Thorac Oncol, Utsunomiya, Tochigi, Japan

[3] Utsunomiya Mem Hosp, Dept Thorac Dis, Utsunomiya, Tochigi, Japan

[4] Oita Univ, Fac Med, Dept Med Oncol, Oita, Japan

[5] Teikyo Univ Hosp, Dept Med Oncol, Tokyo, Japan

[6] Japanese Red Cross Okayama Hosp, Dept Resp Med, Okayama, Japan

[7] Niigata Canc Ctr Hosp, Internal Med, Niigata, Japan

[8] Nagasaki Univ, Grad Sch Biomed Sci, Dept Resp Med, Nagasaki, Japan

[9] Ibaraki Cent Hosp, Dept Resp Med, Ibaraki Canc Ctr, Ibaraki, Japan

[10] Fukushima Med Univ, Dept Pulm Med, Fukushima, Japan

[11] St Marianna Univ, Sch Med, Yokohama City Seibu Hosp, Dept Resp Internal Med, Yokohama, Kanagawa, Japan

[12] Gunma Prefectural Canc Ctr, Dept Resp Med, Gunma, Japan

[13] Yokohama Municipal Citizens Hosp, Dept Resp Med, Yokohama, Kanagawa, Japan

[14] Oita Prefectural Hosp, Dept Thorac Oncol, Oita, Japan

[15] Shizuoka Canc Ctr, Clin Trial Coordinat Off, Shizuoka, Japan

[16] St Lukes Int Univ & Hosp, Collaborat Res Lab, Tokyo, Japan

[17] Yokohama Municipal Citizens Hosp, Dept Resp Med & Med Oncol, Yokohama, Kanagawa, Japan

来源：

ANNALS OF ONCOLOGY | 2020年 / 31卷

关键词：

D O I：

10.1016/j.annonc.2020.08.1685

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1371P

引用

页码：S875 / S875

页数：1

共 50 条

[1] A Randomized Phase II Study of Maintenance Bevacizumab, Pemetrexed or Bevacizumab Plus Pemetrexed for Advanced Non-squamous Non-small Cell Lung Cancer
Yoshida, Hironori
Kim, Young Hak
Sakamori, Yuichi
Nagai, Hiroki
Ozasa, Hiroaki
Kaneda, Toshihiko
Yoshioka, Hiroshige
Nakagawa, Hiroaki
Tomii, Keisuke
Okada, Asuka
Yoshimura, Kenichi
Hirabayashi, Masataka
Hirai, Toyohiro
[J]. ANTICANCER RESEARCH, 2020, 40 (05) : 2981 - 2987
[2] Randomized, Phase II study of pemetrexed plus bevacizumab versus pemetrexed alone after treatment with cisplatin, pemetrexed, and bevacizumab in advanced non-squamous, non-small cell lung cancer: TORG (thoracic oncology research group) 1321
Kasai, Takashi
Mori, Kiyoshi
Nakamura, Yoichi
Seki, Nobuhiko
Ichikawa, Yasuko
Saito, Haruhiro
Kondo, Tetsuro
Nishikawa, Kazuo
Otsu, Satoshi
Bessho, Akihiro
Tanaka, Hiroshi
Yamaguchi, Hiroyuki
Kaburagi, Takayuki
Imai, Hisao
Mori, Keita
Ohtake, Junya
Okamoto, Hiroaki
[J]. CANCER MEDICINE, 2023, 12 (14): : 14988 - 14999
[3] Phase II Trial of Carboplatin, Pemetrexed, Bevacizumab in Advanced non-Small Cell (non-Squamous) Lung Cancer
Guarino, Michael J.
Masters, Gregory A.
Biggs, David D.
[J]. JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S698 - S698
[4] Switch maintenance therapy with docetaxel and bevacizumab after induction therapy with cisplatin, pemetrexed, and bevacizumab in advanced non-squamous non-small cell lung cancer: a phase II study
Koji Nishimoto
Masato Karayama
Naoki Inui
Hideki Yasui
Hironao Hozumi
Yuzo Suzuki
Kazuki Furuhashi
Tomoyuki Fujisawa
Noriyuki Enomoto
Yutaro Nakamura
Nao Inami
Shun Matsuura
Yusuke Kaida
Takashi Matsui
Kazuhiro Asada
Hiroyuki Matsuda
Masato Fujii
Mikio Toyoshima
Shiro Imokawa
Takafumi Suda
[J]. Medical Oncology, 2018, 35
[5] Phase II study of cisplatin/pemetrexed combined with bevacizumab followed by pemetrexed/bevacizumab maintenance therapy in patients with EGFR-wild advanced non-squamous non-small cell lung cancer
Fukushima, Toshirou
Wakatsuki, Yuuki
Kobayashi, Takashi
Sonehara, Kei
Tateishi, Kazunari
Yamamoto, Manabu
Masubuchi, Takeshi
Yoshiike, Fumiaki
Hirai, Kazuya
Hachiya, Tsutomu
Koizumi, Tomonobu
[J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 81 (06) : 1043 - 1050
[6] Phase II study of cisplatin/pemetrexed combined with bevacizumab followed by pemetrexed/bevacizumab maintenance therapy in patients with EGFR-wild advanced non-squamous non-small cell lung cancer
Toshirou Fukushima
Yuuki Wakatsuki
Takashi Kobayashi
Kei Sonehara
Kazunari Tateishi
Manabu Yamamoto
Takeshi Masubuchi
Fumiaki Yoshiike
Kazuya Hirai
Tsutomu Hachiya
Tomonobu Koizumi
[J]. Cancer Chemotherapy and Pharmacology, 2018, 81 : 1043 - 1050
[7] Switch maintenance therapy with docetaxel and bevacizumab after induction therapy with cisplatin, pemetrexed, and bevacizumab in advanced non-squamous non-small cell lung cancer: a phase II study
Nishimoto, Koji
Karayama, Masato
Inui, Naoki
Yasui, Hideki
Hozumi, Hironao
Suzuki, Yuzo
Furuhashi, Kazuki
Fujisawa, Tomoyuki
Enomoto, Noriyuki
Nakamura, Yutaro
Inami, Nao
Matsuura, Shun
Kaida, Yusuke
Matsui, Takashi
Asada, Kazuhiro
Matsuda, Hiroyuki
Fujii, Masato
Toyoshima, Mikio
Imokawa, Shiro
Suda, Takafumi
[J]. MEDICAL ONCOLOGY, 2018, 35 (07)
[8] Phase II study of pemetrexed and carboplatin plus bevacizumab, followed by maintenance pemetrexed and bevacizumab in Japanese patients with non-squamous non-small cell lung cancer
Yokoi, Takashi
Torii, Yoshitaro
Katashiba, Yuichi
Sugimoto, Hiroyuki
Tanijiri, Tsutomu
Ogata, Makoto
Inagaki, Noriko
Kibata, Kayoko
Hayashi, Mina
Niki, Maiko
Shimizu, Toshiki
Miyara, Takayuki
Kurata, Takayasu
Nomura, Shosaku
[J]. ONCOLOGY LETTERS, 2014, 8 (06) : 2453 - 2457
[9] Multicenter phase II study of cisplatin, pemetrexed, plus bevacizumab followed by maintenance pemetrexed plus bevacizumab for patients with advanced or recurrent non-squamous non-small cell lung cancer: MAP study
Tsutani, Y.
Miyata, Y.
Masuda, T.
Fujitaka, K.
Doi, M.
Awaya, Y.
Kuyama, S.
Kitaguchi, S.
Ueda, K.
Okada, M.
[J]. ANNALS OF ONCOLOGY, 2017, 28 : 137 - 137
[10] Maintenance therapy with pemetrexed and bevacizumab versus pemetrexed monotherapy after induction therapy with carboplatin, pemetrexed, and bevacizumab in patients with advanced non-squamous non small cell lung cancer
Karayama, Masato
Inui, Naoki
Fujisawa, Tomoyuki
Enomoto, Noriyuki
Nakamura, Yutaro
Kuroishi, Shigeki
Yokomura, Koshi
Koshimizu, Naoki
Sato, Masaki
Toyoshima, Mikio
Shirai, Toshihiro
Masuda, Masafumi
Yamada, Takashi
Imokawa, Shiro
Suda, Takafumi
[J]. EUROPEAN JOURNAL OF CANCER, 2016, 58 : 30 - 37

← 1 2 3 4 5 →